PTEN and prostate cancer: To date, AI-based studies have been applied to prostate cancer pathology to assist with diagnosis, Gleason grading, prognosis, as as well as predict underlying molecular aberrations such as phosphatase and tensin homology (PTEN) loss [2, 28, 29].